Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05429567
Other study ID # NIRVANA
Secondary ID
Status Completed
Phase Phase 1
First received
Last updated
Start date March 1, 2021
Est. completion date February 28, 2022

Study information

Verified date June 2022
Source Egymedicalpedia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To enhance post-operative pain management, patient-controlled intravenous analgesia (PCIA) has been employed. The fentanyl background PCIA therapy was created to solve the limitations of IV-based PCIA, such as programming errors, mobility limitations, and the risk of needle stick injuries. The goal of this trial was to observe how fentanyl patient-controlled intravenous analgesia pump (PCIA) and background infusion is worked in patients with post-total hip replacement analgesia.


Description:

Significant efforts to enhance the treatment of postoperative pain have resulted in the formulation and implementation of pain management guidelines, as well as the introduction of acute pain services in several hospitals during the last two decades. Recent research, however, suggests that postoperative pain is still poorly controlled . Hip replacement procedures are prevalent among the elderly, and they are significantly more painful . The patient may suffer greatly as a result of the pain, which can also affect physiological functioning caused by hormonal changes caused by sympathetic nervous system activation . Anaesthesiologists and patients alike are concerned about pain management following major surgery. It should also be mentioned that every pain management medication has certain side effects, especially when an opioid is utilized . In the clinical ICU, patient-controlled intravenous analgesia (PCIA) has been used to improve postoperative pain management. Titrate analgesics according to demand. It typically provides better pain management and increases patient satisfaction when compared to "on-demand" opioid injections . The settings programmed into the PCIA machine, such as the bolus dosage, lockout interval, dose restrictions, and background infusion, are included in the PCIA prescription. Each of these factors might have an impact on the safety and efficacy of PCIA. A new fentanyl-based PCIA therapy has been developed to overcome constraints associated with PCIA provided by IV, such as programming mistakes, mobility limits, and the danger of needle stick injuries. Prommer and colleagues demonstrated that a fentanyl dosage delivered through PCIA resulted in a mean C max of 1.954 ug/L and a mean absorption of 39.5 ug fentanyl per 10-minute dose delivery time .


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date February 28, 2022
Est. primary completion date February 1, 2022
Accepts healthy volunteers No
Gender All
Age group N/A to 40 Years
Eligibility Inclusion Criteria: - Patients with total fracture of Hip bones Exclusion Criteria: 1. History of mental or neurological complaints, 2. Opioid and local anaesthetic allergies, 3. Opioid tolerance, 4. Smoking history, 5. local infection, 6. cemented total hip arthroplasty (THA), revision THA, 7. preoperative DVT, 8. renal failure, 9. bleeding tendency due to anticoagulant therapy

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Fentanyl
All patients underwent combined spinal and epidural anesthesia (CSEA) with 2 ml of 0.5 % hyperbaric bupivacaine and 25 ug fentanyl administered using a 27-gauge Whitacre spinal needle and an 18-gauge Tuohy needle in the epidural space. The epidural space was identified utilizing the loss of resistance approach

Locations

Country Name City State
Egypt October 6 University Giza Cairo

Sponsors (2)

Lead Sponsor Collaborator
Egymedicalpedia October 6 University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fentanyl Background Effectiveness of Patient-Controlled Intravenous Analgesia (PCIA) With Fentanyl Background Infusion for Total Hip Replacement from 0 hours to 36 hours after the completion of the operation
See also
  Status Clinical Trial Phase
Completed NCT04774562 - The Effect of Video-Assisted Discharge Education After Total Hip Replacement Surgery N/A
Recruiting NCT02793934 - The Pilot Project Development Of MEdical Rehabilitation System in Russian Federation
Completed NCT02554149 - Radiological Measurement of Femoral Stem Version Using Lateral Decubitus Method: A Prospective Study N/A
Completed NCT01228162 - Influence of Muscle Relaxation With Rocuronium Bromide During General Anaesthesia on Muscle Trauma and Postoperative Analgetic Consumption in Patients With Total Hip Prosthesis Implantation Phase 4
Completed NCT00219921 - Postoperative Analgesia After Total Hip Replacement Phase 3
Completed NCT02644096 - Rehabilitation of Patients After THR - Based on Patients´Selfrated Health Phase 1
Completed NCT02720471 - Local Analgesia Versus Local Peroperative Infiltration After Total Hip Replacement Phase 3
Completed NCT03218267 - The Postural Control in Patients After Total Hip Replacement N/A
Recruiting NCT03120312 - Short Term and Long Term Outcome for Elderly Patients Treated With Total Hip Replacement
Withdrawn NCT01523418 - Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement) N/A
Recruiting NCT01782859 - Effect of Steroids on Thrombosis (Blood Clot Formation) and Inflammation in Patients Undergoing Hip Surgery N/A
Completed NCT00889148 - Morphine COnsumption in Joint Replacement Patients, With and Without GaBapentin Treatment, a RandomIzed ControlLEd Study N/A
Completed NCT05375565 - Comparative Effects of Weight Bearing and Non-weight Bearing Exercises in Patients With Total Hip Replacement N/A
Completed NCT04166539 - Neurotoxicity and Cardiotoxicity in Total Joint Arthroplasty
Completed NCT03072706 - Evaluation of X-ray, Acetabular Guides and CT in THR N/A
Not yet recruiting NCT02272205 - Evaluation of Conventional Antibiotic Prophylaxis During a Change of Hip or Knee Infected at a Time N/A
Completed NCT01522014 - Randomized Clinical Trial of Ceramic Bearing Primary Total Hip Arthroplasty Phase 4
Completed NCT06169878 - Efficiency of the Adjustable Lower Extremity Abduction Apparatus After Total Hip Replacement Surgery N/A
Not yet recruiting NCT06409312 - Digital Healthcare App After Total Hip Arthroplasty N/A
Recruiting NCT03240484 - Examining Effects of Spinal Fusion on Outcomes Following Total Hip Replacement